Use of Real‐World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Use of Real‐World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 111, Issue 1, Pages 77-89
Publisher
Wiley
Online
2021-11-29
DOI
10.1002/cpt.2480
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic Delay in Patients with Eosinophilic Gastritis and/or Duodenitis: A Population-Based Study
- (2021) Mirna Chehade et al. Journal of Allergy and Clinical Immunology-In Practice
- Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic
- (2021) Ziad Bakouny et al. JAMA Oncology
- Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
- (2021) Raymond A. Harvey et al. JAMA Internal Medicine
- Drugs in COVID‐19 Clinical Trials: Predicting Transporter‐Mediated Drug‐Drug Interactions Using In Vitro Assays and Real‐World Data
- (2021) Sook Wah Yee et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 2: a discussion of chemical and biological data
- (2021) Andreas Bender et al. DRUG DISCOVERY TODAY
- Artificial intelligence to deep learning: machine intelligence approach for drug discovery
- (2021) Rohan Gupta et al. MOLECULAR DIVERSITY
- Evaluating eligibility criteria of oncology trials using real-world data and AI
- (2021) Ruishan Liu et al. NATURE
- COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients
- (2021) Mark Stewart et al. PLoS One
- Real-world evidence and product development: Opportunities, challenges and risk mitigation
- (2021) Poobalan Naidoo et al. WIENER KLINISCHE WOCHENSCHRIFT
- Quantitative Image Analysis for Tissue Biomarker Use
- (2021) Haydee Lara et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Demographic diversity of participants in Pfizer sponsored clinical trials in the United States
- (2021) Melinda Rottas et al. Contemporary Clinical Trials
- The Contribution of Machine Learning in the Validation of Commercial Wearable Sensors for Gait Monitoring in Patients: A Systematic Review
- (2021) Théo Jourdan et al. SENSORS
- TrendyGenes, a computational pipeline for the detection of literature trends in academia and drug discovery
- (2021) Guillermo Serrano Nájera et al. Scientific Reports
- A DICOM dataset for evaluation of medical image de-identification
- (2021) Michael Rutherford et al. Scientific Data
- Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients
- (2021) David F. Niedrig et al. Journal of Clinical Medicine
- Organoid Technology: A Reliable Developmental Biology Tool for Organ-Specific Nanotoxicity Evaluation
- (2021) Minakshi Prasad et al. Frontiers in Cell and Developmental Biology
- Artificial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis
- (2021) Sergei Bedrikovetski et al. BMC CANCER
- Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold
- (2021) Li-Feng Hu et al. EXPERIMENTAL CELL RESEARCH
- Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer
- (2021) Payal D. Shah et al. GYNECOLOGIC ONCOLOGY
- Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
- (2020) Olivier J. Wouters et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Opportunities and challenges in using real-world data for health care
- (2020) Vivek A. Rudrapatna et al. JOURNAL OF CLINICAL INVESTIGATION
- How Can Law and Policy Advance Quality in Genomic Analysis and Interpretation for Clinical Care?
- (2020) Barbara J. Evans et al. JOURNAL OF LAW MEDICINE & ETHICS
- Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: A systematic literature review and meta-analysis
- (2020) Kenneth I. Ataga et al. PLoS One
- Use of real‐world data to emulate a clinical trial and support regulatory decision‐making: assessing the impact of temporality, comparator choice and methods of adjustment
- (2020) Devin Abrahami et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Dissecting the journey to breast cancer diagnosis in sub‐Saharan Africa: Findings from the multicountry ABC‐DO cohort study
- (2020) Milena Foerster et al. INTERNATIONAL JOURNAL OF CANCER
- Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
- (2020) Lorenzo Galluzzi et al. Nature Reviews Clinical Oncology
- Responsible, practical genomic data sharing that accelerates research
- (2020) James Brian Byrd et al. NATURE REVIEWS GENETICS
- Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
- (2020) Hyoung Kim et al. Nature Communications
- A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions
- (2020) Tamer N. Jarada et al. Journal of Cheminformatics
- Bridging the Gap Between RCTs and RWE Through Endpoint Selection
- (2020) Robert J. LoCasale et al. Therapeutic Innovation & Regulatory Science
- Evolving use of real-world evidence in the regulatory process: a focus on immuno-oncology treatment and outcomes
- (2020) John C O’Donnell et al. Future Oncology
- Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
- (2020) David E. Gordon et al. SCIENCE
- Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative
- (2020) Lucinda S. Orsini et al. VALUE IN HEALTH
- Diagnosis-wide analysis of COVID-19 complications: an exposure-crossover study
- (2020) William Murk et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory From the American Heart Association
- (2020) Keith Churchwell et al. CIRCULATION
- Disease course and treatment patterns in progressive supranuclear palsy: A real-world study
- (2020) John C. Morgan et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The prevalence of MS in the United States
- (2019) Mitchell T. Wallin et al. NEUROLOGY
- A new way to estimate neurologic disease prevalence in the United States
- (2019) Lorene M. Nelson et al. NEUROLOGY
- Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study
- (2019) Xiao-Fan Zhu et al. ACTA HAEMATOLOGICA
- Re‐identifiability of genomic data and the GDPR
- (2019) Mahsa Shabani et al. EMBO REPORTS
- Applications of machine learning in drug discovery and development
- (2019) Jessica Vamathevan et al. NATURE REVIEWS DRUG DISCOVERY
- Nonrandomized real‐world evidence to support regulatory decision‐making: Process for a randomized trial replication project
- (2019) Jessica M. Franklin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Overcoming Regulatory Aversion to Novel Methods of Evidence Generation
- (2019) Elodie Baumfeld Andre et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Signaling Pathways Project, an integrated ‘omics knowledgebase for mammalian cellular signaling pathways
- (2019) Scott A. Ochsner et al. Scientific Data
- Beyond the Randomized Clinical Trial: Innovative Data Science to Close the Pediatric Evidence Gap
- (2019) Sebastiaan C. Goulooze et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Trial designs using real‐world data: The changing landscape of the regulatory approval process
- (2019) Elodie Baumfeld Andre et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Mechanisms of antimicrobial resistance among hospital-associated pathogens
- (2018) Ayesha Khan et al. Expert Review of Anti-Infective Therapy
- Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature
- (2018) Katharina Schwarze et al. GENETICS IN MEDICINE
- Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity
- (2018) Mwangi J. Murage et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Progress and potential in organoid research
- (2018) Giuliana Rossi et al. NATURE REVIEWS GENETICS
- The inclusion of real world evidence in clinical development planning
- (2018) Reynaldo Martina et al. Trials
- Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database
- (2018) Michael S. Broder et al. BMC Pulmonary Medicine
- Predictive biomarkers of response for immune checkpoint inhibitors in non–small-cell lung cancer
- (2018) Arsela Prelaj et al. EUROPEAN JOURNAL OF CANCER
- Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia
- (2018) Rachel Halpern et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Measuring prevalence and incidence of chronic conditions in claims and electronic health record databases
- (2018) Jeremy A Rassen et al. Clinical Epidemiology
- Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0
- (2017) Shirley V. Wang et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making
- (2017) Marc L. Berger et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Beyond imaging: The promise of radiomics
- (2017) Michele Avanzo et al. Physica Medica-European Journal of Medical Physics
- Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making
- (2017) Marc L. Berger et al. VALUE IN HEALTH
- Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity
- (2016) M. Koehler et al. ANNALS OF ONCOLOGY
- Natural history of diseases: Statistical designs and issues
- (2016) Nicholas P. Jewell CLINICAL PHARMACOLOGY & THERAPEUTICS
- Innovation in the pharmaceutical industry: New estimates of R&D costs
- (2016) Joseph A. DiMasi et al. JOURNAL OF HEALTH ECONOMICS
- Defining SOD1 ALS natural history to guide therapeutic clinical trial design
- (2016) Taha Bali et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Changing R&D models in research-based pharmaceutical companies
- (2016) Alexander Schuhmacher et al. Journal of Translational Medicine
- De-identification of Medical Images with Retention of Scientific Research Value
- (2015) Stephen M. Moore et al. RADIOGRAPHICS
- Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model
- (2015) Howard I. Scher et al. PLoS One
- Prevalence of Eosinophilic Esophagitis in the United States
- (2013) Evan S. Dellon et al. Clinical Gastroenterology and Hepatology
- A Proposal for Integrated Efficacy-to-Effectiveness (E2E) Clinical Trials
- (2013) H P Selker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
- (2011) Sarah J Tabrizi et al. LANCET NEUROLOGY
- How to improve R&D productivity: the pharmaceutical industry's grand challenge
- (2010) Steven M. Paul et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started